Mainz Biomed N.V. financial data

Symbol
MYNZ on Nasdaq
Industry
Pharmaceutical Preparations
Location
Robert Koch Strasse 50, Mainz, Germany
State of incorporation
Netherlands
Fiscal year end
December 31
Former names
Mainz Biomed B.V. (to 11/12/2021)
Latest financial report
20-F - Q4 2023 - Apr 9, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.2M shares +44.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1 USD
Research And Development Expense 9.59M USD +91.1%
General And Administrative Expense 11.4M USD -25%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 15.4M USD -23.9%
Liabilities 12.2M USD +97.9%